Antidepressant response | Parkinson’s disease | Oral cancer

Neural signature predicts antidepressant response; test distinguishes Parkinson's disease from related condition; neurons in oral cancer

February 25, 2020 Edition Neural signature predicts antidepressant response Researchers identified specific patterns of brain activity that predict whether someone with depression is likely to respond to a common antidepressant. Test distinguishes Parkinson's disease from related condition A test that uses samples of cerebrospinal fluid was able to distinguish Parkinson's disease from a related condition called multiple system atrophy with 95% accuracy. Neurons play role in oral cancer Scientists discovered a new role for nerves in oral cancer progression, in which tumor cells send genetic messages that transform nerves into cancer-promoting agents. Popular Stories Drug activates brown fat, improves glucose metabolism in healthy women How stress causes gray hair How brown fat improves metabolism Researchers find cause of new autoinflammatory disease Alcohol-related deaths increasing nationwide Connect with Us Facebook RSS Feed Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®      This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612